Cargando…
Migraine Frequency Decrease Following Prolonged Medical Cannabis Treatment: A Cross-Sectional Study
Background: Medical cannabis (MC) treatment for migraine is practically emerging, although sufficient clinical data are not available for this indication. This cross-sectional questionnaire-based study aimed to investigate the associations between phytocannabinoid treatment and migraine frequency. M...
Autores principales: | Aviram, Joshua, Vysotski, Yelena, Berman, Paula, Lewitus, Gil M., Eisenberg, Elon, Meiri, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348860/ https://www.ncbi.nlm.nih.gov/pubmed/32526965 http://dx.doi.org/10.3390/brainsci10060360 |
Ejemplares similares
-
Prolonged Medical Cannabis Treatment is Associated With Quality of Life Improvement and Reduction of Analgesic Medication Consumption in Chronic Pain Patients
por: Aviram, Joshua, et al.
Publicado: (2021) -
Sex differences in medical cannabis-related adverse effects
por: Aviram, Joshua, et al.
Publicado: (2022) -
Cannabinoid and Terpenoid Doses are Associated with Adult ADHD Status of Medical Cannabis Patients
por: Hergenrather, Jeffrey Y., et al.
Publicado: (2020) -
The Effectiveness and Safety of Medical Cannabis for Treating Cancer Related Symptoms in Oncology Patients
por: Aviram, Joshua, et al.
Publicado: (2022) -
Short-Term Medical Cannabis Treatment Regimens Produced Beneficial Effects among Palliative Cancer Patients
por: Aviram, Joshua, et al.
Publicado: (2020)